Publications by authors named "Jonathan Mahlow"

Claim this Profile
H
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry.
Diane Wilcock, Deepika Sirohi, Joshua F Coleman, Parisa Adelhardt, Jong Taek Kim, Jonathan Mahlow

Am J Clin Pathol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas Database.
Daniel Albertson, Marc Barry, Ting Liu, Jonathan Mahlow, Deepika Sirohi

Int J Surg Pathol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.
Cameron Beech, Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow

Appl Immunohistochem Mol Morphol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0).
Diane Wilcock, Deepika Sirohi, Daniel Albertson, Allison S Cleary, Joshua F Coleman, Jonathan Mahlow

Arch Pathol Lab Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios.
Ankur R Sangoi, Harrison Tsai, Lara Harik, Jonathan Mahlow, Maria Tretiakova

Histopathology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer.
Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow, Jolanta Jedrzkiewicz

Arch Pathol Lab Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors.
Valarie McMurtry, Jonathan Mahlow, Joshua F Coleman, Georgios Deftereos, Rakhi Jattani

Am J Clin Pathol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis